dihexa clinical trial human studies trials Dihexa Dihexa has real research behind

With these capabilities, BPC 157 therapy can recover glaucomatous rats, normalize intraocular pressure, maintain retinal integrity, recover pupil function, recover retinal ischemia, and corneal injuries (i.e., maintained transparency after complete corneal abrasion, corneal ulceration, and counteracted dry eye after lacrimal gland removal or corneal insensitivity)

Cellular Turnover and Pigmentation One of the less-publicized but clinically notable effects of GHK-Cu is its influence on cellular turnover rate

Osmotic blood-brain barrier modification: monoclonal antibody, albumin, and methotrexate delivery to cerebrospinal fluid and brain

Annu Rev Med

The flourishing and use of various innovations to achieve their goals

Cell experiments and controlled experimental animal models can help researchers study possible mechanisms, but they cannot establish safety or effectiveness for human or veterinary use